Post-approval studies (Phase 4)Study completedNCT00138970
What this trial is testing
Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk
Who this might be right for
Renal Transplant Recipients
University of Oslo School of Pharmacy 70